068760 — Celltrion Pharm Share News
0.000.00%
Last trade - 00:00- KR₩2tn
- KR₩2tn
- KR₩536bn
Brief: Celltrion Pharm To Cancel 14 Billion Won Worth Of Own Shares
Brief: Celltrion Pharm 2025 Operating Profit 56 Billion Won, Up 50.7% From Year Earlier
South Korea approves Celltrion's COVID-19 treatment for use
S.Korea Celltrion's candidate COVID-19 drug gets approval for special-case use
S.Korea's Celltrion: Surges as co completes patient recruitment for COVID-19 drug trial
S.Korea's Celltrion jumps on contract to distribute COVID-19 test kits in U.S.
S.Korea pharma Celltrion's COVID test gets U.S. emergency use authorisation
S.Korea pharma Celltrion affiliates jump on merger announcement
S.Korea's Celltrion to merge with affiliates to set up holding company structure
Brief: Celltrion Says Internally Considering Merger Of Its Affiliates, But Nothing Has Been Decided
S.Korean stocks climb amid cautious optimism after Sino-U.S. trade deal
S.Korea's Celltrion, affiliates jump as chairman hints at merger
S.Korean stocks edge higher on bargain hunting; down 0.8 pct for week
Brief: Celltrion Pharm Announces Merger With Its Unlisted Affiliate
S.Korean stocks flat amid global uncertainties; won slumps to 2-week low
S.Korea's Celltrion hits nearly 1-year low on lacklustre Q3 earnings
S.Korean stocks edge lower tracking weakness across broader Asia
S.Korea's Celltrion hits nearly 1-year low on lacklustre Q3 earnings
U.S. FDA panel backs Celltrion copycat drug of Roche blood cancer drug